XML 20 R9.htm IDEA: XBRL DOCUMENT v3.25.2
Consolidated Statements of Cash Flows (unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Cash flows from operating activities:    
Net income $ 378,600 $ 270,520
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation 15,592 16,756
Amortization 21,159 20,871
Equity in earnings of unconsolidated affiliate (62,387) (65,862)
Distributions received from unconsolidated affiliate 67,130 71,478
Stock-based compensation 28,029 23,528
Provision for losses on receivables 521 882
Deferred income tax expense (498) (14,539)
Net gain from investments (2,252) (2,922)
Net gain from business divestiture (94,412) 0
Change in other long-term liabilities 1,189 2,452
Change in other assets (3,456) (5,960)
Contract costs capitalized, net of amortization (1,758) 246
Contingent consideration fair value adjustments (2,354) 0
Insurance rebates received for Health and Welfare Benefit Plan Trust 14,500 0
Insurance rebates transferred to Health and Welfare Benefit Plan Trust (14,500) 0
Other (1,423) (1,375)
Change in current assets and liabilities:    
Receivables from investment products 5,023 7,923
Receivables (79,422) (89,070)
Other current assets (6,321) (1,068)
Advances due from unconsolidated affiliate 47,485 51,942
Accounts payable 3 (1,415)
Accrued liabilities (68,279) (54,188)
Deferred revenue 836 (3,169)
Total adjustments (135,595) (43,490)
Net cash provided by operating activities 243,005 227,030
Cash flows from investing activities:    
Additions to property and equipment (12,451) (20,809)
Additions to capitalized software (14,466) (12,670)
Purchases of marketable securities (85,681) (102,895)
Purchases of interest in limited partnerships (566) 0
Prepayments and maturities of marketable securities 65,168 82,241
Proceeds from fixed asset dispositions 1,165 1,180
Proceeds from business divestiture 116,020 0
Other investing activities (3,921) (8,129)
Net cash provided by/(used in) investing activities 65,268 (61,082)
Cash flows from financing activities:    
Purchase and retirement of common stock (383,304) (163,774)
Proceeds from issuance of common stock 87,381 54,425
Payment of dividends (123,297) (120,338)
Net cash used in financing activities (419,220) (229,687)
Effect of exchange rate changes on cash, cash equivalents and restricted cash 17,103 (2,667)
Net decrease in cash, cash equivalents and restricted cash (93,844) (66,406)
Cash, cash equivalents and restricted cash, beginning of period 840,193 834,998
Cash, cash equivalents and restricted cash, end of period $ 746,349 $ 768,592